BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20009501)

  • 1. Prevalence and risk factors of albuminuria in Type 2 diabetes in Bahrain.
    Al-Salman RA; Al-Basri HA; Al-Sayyad AS; Hearnshaw HM
    J Endocrinol Invest; 2009 Oct; 32(9):746-51. PubMed ID: 20009501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hypertension: data from the Korean Epidemiology Study on Hypertension III (KEY III study).
    Yang CW; Park JT; Kim YS; Kim YL; Lee YS; Oh YS; Kang SW
    Nephrol Dial Transplant; 2011 Oct; 26(10):3249-55. PubMed ID: 21372264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross sectional study.
    Meisinger C; Heier M; Landgraf R; Happich M; Wichmann HE; Piehlmeier W
    BMC Health Serv Res; 2008 Nov; 8():226. PubMed ID: 18986536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
    Idowu AA; Ajose AO; Adedeji AT; Adegoke AO; Jimoh KA
    Ghana Med J; 2017 Jun; 51(2):56-63. PubMed ID: 28955101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of albuminuria among diabetic patients in a primary care setting in Singapore.
    Lee ES; Tang WE
    Singapore Med J; 2015 Dec; 56(12):681-6. PubMed ID: 26702164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.
    Lu B; Wen J; Song XY; Dong XH; Yang YH; Zhang ZY; Zhao NQ; Ye HY; Mou B; Chen FL; Liu Y; Shen Y; Wang XC; Zhou LN; Li YM; Zhu XX; Hu RM
    Diabetes Res Clin Pract; 2007 Feb; 75(2):184-92. PubMed ID: 16893584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania.
    Lutale JJ; Thordarson H; Abbas ZG; Vetvik K
    BMC Nephrol; 2007 Jan; 8():2. PubMed ID: 17224056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective.
    Pan CY; Ho LT; Soegondo S; Prodjosudjadi W; Suwanwalaikorn S; Lim SC; Chan TM; Chow KW; Thoenes M; Choi DS;
    Diabetes Technol Ther; 2008 Oct; 10(5):397-403. PubMed ID: 18715217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of and Factors Associated with Nephropathy in Diabetic Patients Attending an Outpatient Clinic in Harare, Zimbabwe.
    Machingura PI; Chikwasha V; Okwanga PN; Gomo E
    Am J Trop Med Hyg; 2017 Feb; 96(2):477-482. PubMed ID: 27994108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between glycaemic level and lipid profile with Albuminuria in Iraqi type 2 diabetes patients - A cross sectional study.
    Hassan Al-Bayati AA; Jawad Al-Khateeb SM
    J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S57-S62. PubMed ID: 35130220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study.
    Rossi MC; Nicolucci A; Pellegrini F; Comaschi M; Ceriello A; Cucinotta D; Giorda C; Valentini U; Vespasiani G; De Cosmo S
    Nephrol Dial Transplant; 2008 Apr; 23(4):1278-84. PubMed ID: 18039647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria and its correlates in type 2 diabetic patients.
    Zakkerkish M; Shahbazian HB; Shahbazian H; Latifi SM; Moravej Aleali A
    Iran J Kidney Dis; 2013 Jul; 7(4):268-76. PubMed ID: 23880803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of microalbuminuria and associated factors among patients with type 2 diabetes mellitus in Botswana.
    Molefe-Baikai OJ; Molefi M; Cainelli F; Rwegerera GM
    Niger J Clin Pract; 2018 Nov; 21(11):1430-1437. PubMed ID: 30417840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Factors Associated with Microalbuminuria among Type 2 Diabetic Patients : A Hospital Based Study.
    Khadka B; Tiwari ML; Timalsina B; Risal P; Gupta S; Acharya D
    JNMA J Nepal Med Assoc; 2018; 56(209):516-521. PubMed ID: 30058635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of microalbuminuria in type 2 diabetes mellitus outpatients at University Sains Malaysia Hospital.
    Abougalambou SS; Abougalambou AS
    Diabetes Metab Syndr; 2013; 7(2):64-7. PubMed ID: 23680242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective.
    Parving HH; Lewis JB; Ravid M; Remuzzi G; Hunsicker LG;
    Kidney Int; 2006 Jun; 69(11):2057-63. PubMed ID: 16612330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with albuminuria in Kuwaiti adults with type 2 diabetes.
    Al-Adsani A
    Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):860-5. PubMed ID: 22805411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and associations of moderately increased albuminuria in patients with type 2 diabetes in United Arab Emirates.
    Arman Rabbani S; Belagodu Sridhar S; Gm Rao P; Javed N; Thomas Kurian M; Mahtab A; Sharma S
    Diabetes Metab Syndr; 2020; 14(6):1865-1870. PubMed ID: 32980790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of microalbuminuria in type 2 diabetic patients in Karachi: Pakistan: a multi-center study.
    Ahmedani MY; Hydrie MZ; Iqbal A; Gul A; Mirza WB; Basit A
    J Pak Med Assoc; 2005 Sep; 55(9):382-6. PubMed ID: 16302472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Diabetic Nephropathy and associated risk factors among type 2 diabetes mellitus patients in Ramallah, Palestine.
    Shahwan MJ; Gacem SA; Zaidi SK
    Diabetes Metab Syndr; 2019; 13(2):1491-1496. PubMed ID: 31336511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.